Title:
OCT製剤
Document Type and Number:
Japanese Patent JP3668225
Kind Code:
B2
Abstract:
An object of the present invention is to provide OCT formulations showing excellent stability. According to the present invention, OCT formulations comprising 1 alpha ,25-dihydroxy-22-oxavitamin D3 (OCT) and a pH modifier are provided.
Inventors:
Ichiro Fujimoto
Application Number:
JP2002522905A
Publication Date:
July 06, 2005
Filing Date:
August 29, 2001
Export Citation:
Assignee:
Chugai Pharmaceutical Co., Ltd.
International Classes:
A61K9/00; A61K31/593; A61K47/02; (IPC1-7): A61K31/593; A61K47/04; A61P3/02; A61P17/00; A61P17/06
Domestic Patent References:
| JP10139669A |
Foreign References:
| WO1994014453A1 | ||||
| WO1991012807A1 | ||||
| WO1990009796A1 |
Attorney, Agent or Firm:
Kazuo Shamoto
Tadashi Masui
Yasushi Kobayashi
Akio Chiba
Hiroyuki Tomita
Keiko Kanemoto
Tadashi Masui
Yasushi Kobayashi
Akio Chiba
Hiroyuki Tomita
Keiko Kanemoto